Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2774605139', 'doi': 'https://doi.org/10.1038/nrurol.2017.190', 'title': 'Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition', 'display_name': 'Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition', 'publication_year': 2017, 'publication_date': '2017-12-05', 'ids': {'openalex': 'https://openalex.org/W2774605139', 'doi': 'https://doi.org/10.1038/nrurol.2017.190', 'mag': '2774605139', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/29205200'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1038/nrurol.2017.190', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S67216020', 'display_name': 'Nature Reviews Urology', 'issn_l': '1759-4812', 'issn': ['1759-4812', '1759-4820'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319908', 'host_organization_name': 'Nature Portfolio', 'host_organization_lineage': ['https://openalex.org/P4310319908', 'https://openalex.org/P4310319965'], 'host_organization_lineage_names': ['Nature Portfolio', 'Springer Nature'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5057758356', 'display_name': 'Arlene O. Siefker‐Radtke', 'orcid': 'https://orcid.org/0000-0002-6328-9599'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Arlene Siefker-Radtke', 'raw_affiliation_strings': ['The University of Texas MD Anderson Cancer Center, 1155 Pressler, Unit 1374, Houston, 77030, Texas, USA'], 'affiliations': [{'raw_affiliation_string': 'The University of Texas MD Anderson Cancer Center, 1155 Pressler, Unit 1374, Houston, 77030, Texas, USA', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5029588412', 'display_name': 'Brendan D. Curti', 'orcid': 'https://orcid.org/0000-0003-3948-2708'}, 'institutions': [{'id': 'https://openalex.org/I2801670537', 'display_name': 'Providence Portland Medical Center', 'ror': 'https://ror.org/015tmw922', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2801670537', 'https://openalex.org/I4210160466', 'https://openalex.org/I94396219']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Brendan Curti', 'raw_affiliation_strings': ['Earle A. Chiles Research Institute, Providence Portland Medical Center, 4805 NE Glisan, Suite 2N82, Portland, 97213, Oregon, USA'], 'affiliations': [{'raw_affiliation_string': 'Earle A. Chiles Research Institute, Providence Portland Medical Center, 4805 NE Glisan, Suite 2N82, Portland, 97213, Oregon, USA', 'institution_ids': ['https://openalex.org/I2801670537']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5057758356'], 'corresponding_institution_ids': ['https://openalex.org/I1343551460'], 'apc_list': None, 'apc_paid': None, 'fwci': 2.521, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 76, 'citation_normalized_percentile': {'value': 0.66366, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 97, 'max': 98}, 'biblio': {'volume': '15', 'issue': '2', 'first_page': '112', 'last_page': '124'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10458', 'display_name': 'Diagnosis and Treatment of Bladder Cancer', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10458', 'display_name': 'Diagnosis and Treatment of Bladder Cancer', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12695', 'display_name': 'Clinical and Pathological Aspects of Urachal Carcinoma', 'score': 0.9966, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/durvalumab', 'display_name': 'Durvalumab', 'score': 0.94399214}, {'id': 'https://openalex.org/keywords/avelumab', 'display_name': 'Avelumab', 'score': 0.89114314}, {'id': 'https://openalex.org/keywords/atezolizumab', 'display_name': 'Atezolizumab', 'score': 0.85300106}, {'id': 'https://openalex.org/keywords/metastatic-urothelial-carcinoma', 'display_name': 'Metastatic Urothelial Carcinoma', 'score': 0.7100581}, {'id': 'https://openalex.org/keywords/biomarkers-for-immunotherapy', 'display_name': 'Biomarkers for Immunotherapy', 'score': 0.573728}, {'id': 'https://openalex.org/keywords/immunotherapy', 'display_name': 'Immunotherapy', 'score': 0.563452}, {'id': 'https://openalex.org/keywords/immune-checkpoint-blockade', 'display_name': 'Immune Checkpoint Blockade', 'score': 0.508622}, {'id': 'https://openalex.org/keywords/cancer-immunoediting', 'display_name': 'Cancer Immunoediting', 'score': 0.507562}, {'id': 'https://openalex.org/keywords/combination-therapies', 'display_name': 'Combination Therapies', 'score': 0.504872}, {'id': 'https://openalex.org/keywords/immune-checkpoint', 'display_name': 'Immune checkpoint', 'score': 0.45118245}], 'concepts': [{'id': 'https://openalex.org/C2777742743', 'wikidata': 'https://www.wikidata.org/wiki/Q19904005', 'display_name': 'Durvalumab', 'level': 5, 'score': 0.94399214}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8997257}, {'id': 'https://openalex.org/C2777381376', 'wikidata': 'https://www.wikidata.org/wiki/Q21083261', 'display_name': 'Avelumab', 'level': 5, 'score': 0.89114314}, {'id': 'https://openalex.org/C2780030458', 'wikidata': 'https://www.wikidata.org/wiki/Q7041828', 'display_name': 'Nivolumab', 'level': 4, 'score': 0.8743181}, {'id': 'https://openalex.org/C2775949291', 'wikidata': 'https://www.wikidata.org/wiki/Q20707748', 'display_name': 'Atezolizumab', 'level': 5, 'score': 0.85300106}, {'id': 'https://openalex.org/C2780057760', 'wikidata': 'https://www.wikidata.org/wiki/Q13896859', 'display_name': 'Pembrolizumab', 'level': 4, 'score': 0.76738155}, {'id': 'https://openalex.org/C2911057145', 'wikidata': 'https://www.wikidata.org/wiki/Q2501186', 'display_name': 'Metastatic Urothelial Carcinoma', 'level': 5, 'score': 0.7100581}, {'id': 'https://openalex.org/C2777701055', 'wikidata': 'https://www.wikidata.org/wiki/Q1427096', 'display_name': 'Immunotherapy', 'level': 3, 'score': 0.7075853}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.5916152}, {'id': 'https://openalex.org/C8891405', 'wikidata': 'https://www.wikidata.org/wiki/Q1059', 'display_name': 'Immune system', 'level': 2, 'score': 0.54353935}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.5203678}, {'id': 'https://openalex.org/C2781433595', 'wikidata': 'https://www.wikidata.org/wiki/Q2459042', 'display_name': 'Ipilimumab', 'level': 4, 'score': 0.49170977}, {'id': 'https://openalex.org/C2780851360', 'wikidata': 'https://www.wikidata.org/wiki/Q21686041', 'display_name': 'Immune checkpoint', 'level': 4, 'score': 0.45118245}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.4292504}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.4222329}, {'id': 'https://openalex.org/C2780352672', 'wikidata': 'https://www.wikidata.org/wiki/Q504775', 'display_name': 'Bladder cancer', 'level': 3, 'score': 0.32501614}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.3210917}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.31301072}, {'id': 'https://openalex.org/C3019882237', 'wikidata': 'https://www.wikidata.org/wiki/Q2501186', 'display_name': 'Urothelial carcinoma', 'level': 4, 'score': 0.29991412}], 'mesh': [{'descriptor_ui': 'D000074322', 'descriptor_name': 'Antineoplastic Agents, Immunological', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D002295', 'descriptor_name': 'Carcinoma, Transitional Cell', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D001749', 'descriptor_name': 'Urinary Bladder Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D061067', 'descriptor_name': 'Antibodies, Monoclonal, Humanized', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D061067', 'descriptor_name': 'Antibodies, Monoclonal, Humanized', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000074322', 'descriptor_name': 'Antineoplastic Agents, Immunological', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D060890', 'descriptor_name': 'B7-H1 Antigen', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D060890', 'descriptor_name': 'B7-H1 Antigen', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D060890', 'descriptor_name': 'B7-H1 Antigen', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014408', 'descriptor_name': 'Biomarkers, Tumor', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D014408', 'descriptor_name': 'Biomarkers, Tumor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D060908', 'descriptor_name': 'CTLA-4 Antigen', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D060908', 'descriptor_name': 'CTLA-4 Antigen', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002295', 'descriptor_name': 'Carcinoma, Transitional Cell', 'qualifier_ui': 'Q000000981', 'qualifier_name': 'diagnostic imaging', 'is_major_topic': False}, {'descriptor_ui': 'D002295', 'descriptor_name': 'Carcinoma, Transitional Cell', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002986', 'descriptor_name': 'Clinical Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000074324', 'descriptor_name': 'Ipilimumab', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000074324', 'descriptor_name': 'Ipilimumab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077594', 'descriptor_name': 'Nivolumab', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000077594', 'descriptor_name': 'Nivolumab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D049268', 'descriptor_name': 'Positron-Emission Tomography', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D061026', 'descriptor_name': 'Programmed Cell Death 1 Receptor', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D061026', 'descriptor_name': 'Programmed Cell Death 1 Receptor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001749', 'descriptor_name': 'Urinary Bladder Neoplasms', 'qualifier_ui': 'Q000000981', 'qualifier_name': 'diagnostic imaging', 'is_major_topic': False}, {'descriptor_ui': 'D001749', 'descriptor_name': 'Urinary Bladder Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1038/nrurol.2017.190', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S67216020', 'display_name': 'Nature Reviews Urology', 'issn_l': '1759-4812', 'issn': ['1759-4812', '1759-4820'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319908', 'host_organization_name': 'Nature Portfolio', 'host_organization_lineage': ['https://openalex.org/P4310319908', 'https://openalex.org/P4310319965'], 'host_organization_lineage_names': ['Nature Portfolio', 'Springer Nature'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/29205200', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.6, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 105, 'referenced_works': ['https://openalex.org/W1501320711', 'https://openalex.org/W169084277', 'https://openalex.org/W1771287927', 'https://openalex.org/W1773771017', 'https://openalex.org/W1820495241', 'https://openalex.org/W1858135205', 'https://openalex.org/W1939981634', 'https://openalex.org/W1941332786', 'https://openalex.org/W1966900148', 'https://openalex.org/W1971208896', 'https://openalex.org/W1981528932', 'https://openalex.org/W2004150448', 'https://openalex.org/W2009720434', 'https://openalex.org/W2016983859', 'https://openalex.org/W2033775272', 'https://openalex.org/W2035660473', 'https://openalex.org/W2039014923', 'https://openalex.org/W2046702136', 'https://openalex.org/W2047475159', 'https://openalex.org/W2053521858', 'https://openalex.org/W2055901890', 'https://openalex.org/W2066671159', 'https://openalex.org/W2068523052', 'https://openalex.org/W2071183770', 'https://openalex.org/W2082205186', 'https://openalex.org/W2084075250', 'https://openalex.org/W2090742614', 'https://openalex.org/W2093773243', 'https://openalex.org/W2098028863', 'https://openalex.org/W2099560139', 'https://openalex.org/W2099609050', 'https://openalex.org/W2100158834', 'https://openalex.org/W2101571970', 'https://openalex.org/W2101670384', 'https://openalex.org/W2103257412', 'https://openalex.org/W2104347254', 'https://openalex.org/W2107752337', 'https://openalex.org/W2109653150', 'https://openalex.org/W2116981696', 'https://openalex.org/W2117552772', 'https://openalex.org/W2118503880', 'https://openalex.org/W2125082756', 'https://openalex.org/W2125616358', 'https://openalex.org/W2126292500', 'https://openalex.org/W2128035403', 'https://openalex.org/W2129540272', 'https://openalex.org/W2131640081', 'https://openalex.org/W2143163879', 'https://openalex.org/W2148706732', 'https://openalex.org/W2149437353', 'https://openalex.org/W2150544967', 'https://openalex.org/W2151488185', 'https://openalex.org/W2154029052', 'https://openalex.org/W2156353875', 'https://openalex.org/W2166662937', 'https://openalex.org/W2177405394', 'https://openalex.org/W2210073947', 'https://openalex.org/W2222086386', 'https://openalex.org/W2260067559', 'https://openalex.org/W2275606382', 'https://openalex.org/W2287821501', 'https://openalex.org/W2289712604', 'https://openalex.org/W2292383635', 'https://openalex.org/W2296049142', 'https://openalex.org/W2325469667', 'https://openalex.org/W2378803961', 'https://openalex.org/W2398131194', 'https://openalex.org/W2409659978', 'https://openalex.org/W2414977199', 'https://openalex.org/W2465221794', 'https://openalex.org/W2466451466', 'https://openalex.org/W2479232428', 'https://openalex.org/W2483319193', 'https://openalex.org/W2491521283', 'https://openalex.org/W2494906840', 'https://openalex.org/W2530516001', 'https://openalex.org/W2540778249', 'https://openalex.org/W2549481046', 'https://openalex.org/W2549712326', 'https://openalex.org/W2554618897', 'https://openalex.org/W2559804019', 'https://openalex.org/W2560367415', 'https://openalex.org/W2560827811', 'https://openalex.org/W2567092281', 'https://openalex.org/W2570618306', 'https://openalex.org/W2572174216', 'https://openalex.org/W2582671354', 'https://openalex.org/W2586210842', 'https://openalex.org/W2586401019', 'https://openalex.org/W2588106160', 'https://openalex.org/W2588211210', 'https://openalex.org/W2588916311', 'https://openalex.org/W2595112364', 'https://openalex.org/W2601621622', 'https://openalex.org/W2604441970', 'https://openalex.org/W2605497049', 'https://openalex.org/W2606367731', 'https://openalex.org/W2606495925', 'https://openalex.org/W2606976048', 'https://openalex.org/W2614700106', 'https://openalex.org/W2724506765', 'https://openalex.org/W2734670400', 'https://openalex.org/W4230094253', 'https://openalex.org/W4232935611', 'https://openalex.org/W884353920'], 'related_works': ['https://openalex.org/W4226329559', 'https://openalex.org/W3144391780', 'https://openalex.org/W3118442307', 'https://openalex.org/W3104083510', 'https://openalex.org/W3000961096', 'https://openalex.org/W2993790564', 'https://openalex.org/W2980194882', 'https://openalex.org/W2925322150', 'https://openalex.org/W2884534038', 'https://openalex.org/W2760849249'], 'abstract_inverted_index': None, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2774605139', 'counts_by_year': [{'year': 2024, 'cited_by_count': 4}, {'year': 2023, 'cited_by_count': 10}, {'year': 2022, 'cited_by_count': 18}, {'year': 2021, 'cited_by_count': 8}, {'year': 2020, 'cited_by_count': 16}, {'year': 2019, 'cited_by_count': 10}, {'year': 2018, 'cited_by_count': 10}], 'updated_date': '2024-08-15T15:01:01.939182', 'created_date': '2017-12-22'}